Posted in | News

Guidant Report 12 Month Follow Up Results from Clinical Trials on Bioabsorbable Everolimus Eluting Stents

May 27 2004

Guidant Corporation today announced results from two clinical trials evaluating everolimus eluting stents. Twelve-month results from the FUTURE II clinical trial will be reviewed by Beverly Lorell, M.D., Guidant vice president and chief medical and technology officer, during the company’s mid-quarter conference call tomorrow, Thursday, May 27. Thirty-day results from the SPIRIT FIRST feasibility study evaluating Guidant’s MULTI-LINK VISION® Coronary Stent System-based drug eluting stent system for the treatment of coronary artery disease were presented by Jan J. Piek, M.D., of the Academic Medical Center, Department of Cardiology, University of Amsterdam, today at the Paris Course on Revascularization (EuroPCR) conference taking place through Friday, May 28.

For more details on the clinical results of the everolimus eluting coronary stent system, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback